{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:12:03Z","timestamp":1759057923762,"version":"3.37.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP22659072","JP24659161"],"award-info":[{"award-number":["JP22659072","JP24659161"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP26670187"],"award-info":[{"award-number":["JP26670187"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K15256"],"award-info":[{"award-number":["JP16K15256"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20ck0106545","JP19ck0106264"],"award-info":[{"award-number":["JP20ck0106545","JP19ck0106264"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"the Smoking Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hamamatsu University School of Medicine","award":["HUSM Grant-in-Aid"],"award-info":[{"award-number":["HUSM Grant-in-Aid"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes and Environ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>DNA adducts, covalent modifications to DNA due to exposure to specific carcinogens, cause the mispairing of DNA bases, which ultimately results in DNA mutations. DNA methylation in the promoter region, another type of DNA base modification, alters the DNA transcription process, and has been implicated in carcinogenesis in humans due to the down-regulation of tumor suppressor genes. Difficulties are associated with demonstrating the existence of DNA adducts or chemically modified bases in the human urological system. Apart from aristolochic acid-DNA adducts, which cause urothelial carcinoma and endemic nephropathy in a particular geographical area (Balkan), limited information is currently available on DNA adduct profiles in renal cell carcinoma and upper urinary tract urothelial carcinoma, including renal pelvic cancer and ureteral cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>To elucidate the significance of DNA adducts in carcinogenesis in the urothelial system, we investigated 53 DNA adducts in the non-tumoral renal parenchyma and non-tumoral renal pelvis of patients with renal cell carcinoma, upper urinary tract urothelial carcinoma, and other diseases using liquid chromatography coupled with tandem mass spectrometry. A comparative analysis of tissue types, the status of malignancy, and clinical characteristics, including lifestyle factors, was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>C5-Methyl-2\u2032-deoxycytidine, C5-hydroxymethyl-2\u2032-deoxycytidine (5hmdC), C5-formyl-2\u2032-deoxycytidine, 2\u2032-deoxyinosine, C8-oxo-2\u2032-deoxyadenosine, and C8-oxo-2\u2032-deoxyguanosine (8-OHdG) were detected in the renal parenchyma and renal pelvis. 8-OHdG was more frequently detected in the renal pelvis than in the renal cortex and medulla (<jats:italic>p<\/jats:italic>\u2009=\u20090.048 and <jats:italic>p<\/jats:italic>\u2009=\u20090.038, respectively). 5hmdC levels were significantly lower in the renal pelvis of urothelial carcinoma patients (<jats:italic>n<\/jats:italic>\u2009=\u200910) than in the urothelium of patients without urothelial carcinoma (<jats:italic>n<\/jats:italic>\u2009=\u200915) (<jats:italic>p<\/jats:italic>\u2009=\u20090.010). Regarding 5hmdC levels in the renal cortex and medulla, Spearman\u2019s rank correlation test revealed a negative correlation between age and 5hmdC levels (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.46, <jats:italic>p<\/jats:italic>\u2009=\u20090.018 and <jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u20090.45, <jats:italic>p<\/jats:italic>\u2009=\u20090.042, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present results revealed a reduction of 5hmdC levels in the non-tumoral urinary tract mucosa of patients with upper urinary tract urothelial carcinoma. Therefore, the urothelial cell epithelia of patients with upper urinary tract cancer, even in non-cancerous areas, may be predisposed to urothelial cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41021-021-00228-9","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T06:34:21Z","timestamp":1638426861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2\u2032-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients"],"prefix":"10.1186","volume":"43","author":[{"given":"Yuto","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9085-5429","authenticated-orcid":false,"given":"Yuji","family":"Iwashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"228_CR1","doi-asserted-by":"publisher","DOI":"10.1201\/9780429258794","volume-title":"The biology of cancer","author":"RA Weinberg","year":"2013","unstructured":"Weinberg RA. The biology of cancer. 2nd ed: Garland science; 2013.","edition":"2"},{"key":"228_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2407-2-29","volume":"2","author":"J Yu","year":"2002","unstructured":"Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J, et al. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer. 2002;2:29.","journal-title":"BMC Cancer"},{"issue":"12","key":"228_CR3","first-page":"3782","volume":"8","author":"A Bearzatto","year":"2002","unstructured":"Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, et al. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Clin Cancer Res. 2002;8(12):3782\u20137.","journal-title":"Clin Cancer Res"},{"issue":"42","key":"228_CR4","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1038\/sj.onc.1209867","volume":"25","author":"MG Lee","year":"2006","unstructured":"Lee MG, Huh JS, Chung SK, Lee JH, Byun DS, Ryu BK, et al. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses. Oncogene. 2006;25(42):5807\u201322.","journal-title":"Oncogene"},{"issue":"6","key":"228_CR5","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/carcin\/bgm014","volume":"28","author":"R Martinez","year":"2007","unstructured":"Martinez R, Setien F, Voelter C, Casado S, Quesada MP, Schackert G, et al. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis. 2007;28(6):1264\u20138.","journal-title":"Carcinogenesis"},{"issue":"1","key":"228_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/cas.14666","volume":"112","author":"Y Totsuka","year":"2021","unstructured":"Totsuka Y, Watanabe M, Lin Y. New horizons of DNA adductome for exploring environmental causes of cancer. Cancer Sci. 2021;112(1):7\u201315.","journal-title":"Cancer Sci"},{"issue":"5\u20136","key":"228_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1089\/ars.2006.8.993","volume":"8","author":"RA Kanaly","year":"2006","unstructured":"Kanaly RA, Hanaoka T, Sugimura H, Toda H, Matsui S, Matsuda T. Development of the adductome approach to detect DNA damage in humans. Antioxid Redox Signal. 2006;8(5\u20136):993\u20131001.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"228_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/carcin\/bgs327","volume":"34","author":"T Matsuda","year":"2013","unstructured":"Matsuda T, Tao H, Goto M, Yamada H, Suzuki M, Wu Y, et al. Lipid peroxidation-induced DNA adducts in human gastric mucosa. Carcinogenesis. 2013;34(1):121\u20137.","journal-title":"Carcinogenesis"},{"issue":"9","key":"228_CR9","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1021\/tx100047d","volume":"23","author":"PH Chou","year":"2010","unstructured":"Chou PH, Kageyama S, Matsuda S, Kanemoto K, Sasada Y, Oka M, et al. Detection of lipid peroxidation-induced DNA adducts caused by 4-oxo-2(E)-nonenal and 4-oxo-2(E)-hexenal in human autopsy tissues. Chem Res Toxicol. 2010;23(9):1442\u20138.","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"228_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41021-021-00186-2","volume":"43","author":"I Ohnishi","year":"2021","unstructured":"Ohnishi I, Iwashita Y, Matsushita Y, Ohtsuka S, Yamashita T, Inaba K, et al. Mass spectrometric profiling of DNA adducts in the human stomach associated with damage from environmental factors. Genes Environ. 2021;43(1):12.","journal-title":"Genes Environ"},{"key":"228_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41021-016-0046-8","volume":"38","author":"H Kasai","year":"2016","unstructured":"Kasai H. What causes human cancer? Approaches from the chemistry of DNA damage. Genes Environ. 2016;38:19.","journal-title":"Genes Environ"},{"issue":"10","key":"228_CR12","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1248\/bpb.b16-00422","volume":"39","author":"M Kumondai","year":"2016","unstructured":"Kumondai M, Hosono H, Orikasa K, Arai Y, Arai T, Sugimura H, et al. CYP2A13 genetic polymorphisms in relation to the risk of bladder Cancer in Japanese smokers. Biol Pharm Bull. 2016;39(10):1683\u20136.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"228_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1248\/bpb.b15-00604","volume":"39","author":"M Kumondai","year":"2016","unstructured":"Kumondai M, Hosono H, Orikasa K, Arai Y, Arai T, Sugimura H, et al. Genetic polymorphisms of CYP2A6 in a case-control study on bladder Cancer in Japanese smokers. Biol Pharm Bull. 2016;39(1):84\u20139.","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"228_CR14","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.urology.2004.06.019","volume":"64","author":"H Miyake","year":"2004","unstructured":"Miyake H, Hara I, Kamidono S, Eto H. Prognostic significance of oxidative DNA damage evaluated by 8-hydroxy-2\u2032-deoxyguanosine in patients undergoing radical nephrectomy for renal cell carcinoma. Urology. 2004;64(5):1057\u201361.","journal-title":"Urology"},{"issue":"4","key":"228_CR15","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1097\/01.ju.0000116617.32728.ca","volume":"171","author":"H Miyake","year":"2004","unstructured":"Miyake H, Hara I, Kamidono S, Eto H. Oxidative DNA damage in patients with prostate cancer and its response to treatment. J Urol. 2004;171(4):1533\u20136.","journal-title":"J Urol"},{"issue":"2","key":"228_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2015.01.018","volume":"359","author":"MJ Gouveia","year":"2015","unstructured":"Gouveia MJ, Santos J, Brindley PJ, Rinaldi G, Lopes C, Santos LL, et al. Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer. Cancer Lett. 2015;359(2):226\u201332.","journal-title":"Cancer Lett"},{"issue":"1\u20132","key":"228_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1383-5718(01)00188-7","volume":"494","author":"VM Arlt","year":"2001","unstructured":"Arlt VM, Pfohl-Leszkowicz A, Cosyns J-P, Schmeiser HH. Analyses of DNA adducts formed by ochratoxin a and aristolochic acid in patients with Chinese herbs nephropathy. Mutat Res. 2001;494(1\u20132):143\u201350.","journal-title":"Mutat Res"},{"issue":"12","key":"228_CR18","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1158\/1055-9965.EPI-16-0219","volume":"25","author":"ML Hoang","year":"2016","unstructured":"Hoang ML, Chen CH, Chen PC, Roberts NJ, Dickman KG, Yun BH, et al. Aristolochic Acid in the etiology of renal cell carcinoma. Cancer Epidemiol Biomark Prev. 2016;25(12):1600\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"23","key":"228_CR19","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","volume":"342","author":"JL Nortier","year":"2000","unstructured":"Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342(23):1686\u201392.","journal-title":"N Engl J Med"},{"issue":"9","key":"228_CR20","first-page":"2025","volume":"56","author":"HH Schmeiser","year":"1996","unstructured":"Schmeiser HH, Bieler CA, Wiessler M, Van Ypersele De Strihou C, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res. 1996;56(9):2025\u20138.","journal-title":"Cancer Res"},{"issue":"8","key":"228_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/em.21732","volume":"53","author":"HH Schmeiser","year":"2012","unstructured":"Schmeiser HH, Kucab JE, Arlt VM, Phillips DH, Hollstein M, Gluhovschi G, et al. Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania. Environ Mol Mutagen. 2012;53(8):636\u201341.","journal-title":"Environ Mol Mutagen"},{"issue":"6","key":"228_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/ki.2011.371","volume":"81","author":"B Jelakovic","year":"2012","unstructured":"Jelakovic B, Karanovic S, Vukovic-Lela I, Miller F, Edwards KL, Nikolic J, et al. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int. 2012;81(6):559\u201367.","journal-title":"Kidney Int"},{"key":"228_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41021-015-0010-z","volume":"37","author":"Y Luan","year":"2015","unstructured":"Luan Y, Xing G, Ren J, Gu J. Role of hepatic cytochrome P450 enzymes in the detoxication of aristolochic acid I; effects on DNA adduct, mutation, and tumor formation. Genes Environ. 2015;37:11.","journal-title":"Genes Environ"},{"issue":"2","key":"228_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234\u201341.","journal-title":"Eur Urol"},{"issue":"1","key":"228_CR25","doi-asserted-by":"publisher","first-page":"e0146302","DOI":"10.1371\/journal.pone.0146302","volume":"11","author":"E Munari","year":"2016","unstructured":"Munari E, Chaux A, Vaghasia AM, Taheri D, Karram S, Bezerra SM, et al. Global 5-Hydroxymethylcytosine levels are profoundly reduced in multiple genitourinary malignancies. PLoS One. 2016;11(1):e0146302.","journal-title":"PLoS One"},{"key":"228_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fgene.2017.00100","volume":"8","author":"DQ Shi","year":"2017","unstructured":"Shi DQ, Ali I, Tang J, Yang WC. New insights into 5hmC DNA modification: generation, Distribution and Function. Front Genet. 2017;8:100.","journal-title":"Front Genet"},{"key":"228_CR27","doi-asserted-by":"crossref","unstructured":"Kharat SS, Ding X, Swaminathan D, Suresh A, Singh M, Sengodan SK, et al. Degradation of 5hmC-marked stalled replication forks by APE1 causes genomic instability. Sci Signal. 2020;13(645):eaba8091.","DOI":"10.1126\/scisignal.aba8091"},{"issue":"2","key":"228_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/pin.12631","volume":"68","author":"Y Kanai","year":"2018","unstructured":"Kanai Y, Nishihara H, Miyagi Y, Tsuruyama T, Taguchi K, Katoh H, et al. The Japanese Society of Pathology Guidelines on the handling of pathological tissue samples for genomic research: standard operating procedures based on empirical analyses. Pathol Int. 2018;68(2):63\u201390.","journal-title":"Pathol Int"},{"issue":"6","key":"228_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1039\/c9tx00067d","volume":"8","author":"W Huang","year":"2019","unstructured":"Huang W, Liu C, Xie L, Wang Y, Xu Y, Li Y. Integrated network pharmacology and targeted metabolomics to reveal the mechanism of nephrotoxicity of triptolide. Toxicol Res (Camb). 2019;8(6):850\u201361.","journal-title":"Toxicol Res (Camb)"},{"issue":"1","key":"228_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10534-020-00260-2","volume":"34","author":"T Guan","year":"2021","unstructured":"Guan T, Xin Y, Zheng K, Wang R, Zhang X, Jia S, et al. Metabolomics analysis of the effects of quercetin on renal toxicity induced by cadmium exposure in rats. Biometals. 2021;34(1):33\u201348.","journal-title":"Biometals"},{"issue":"1","key":"228_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1186\/s12885-019-6354-1","volume":"19","author":"Z Wang","year":"2019","unstructured":"Wang Z, Liu X, Liu X, Sun H, Guo Z, Zheng G, et al. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma. BMC Cancer. 2019;19(1):1195.","journal-title":"BMC Cancer"},{"issue":"8","key":"228_CR32","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/nar\/gkl099","volume":"34","author":"MA Kalam","year":"2006","unstructured":"Kalam MA, Haraguchi K, Chandani S, Loechler EL, Moriya M, Greenberg MM, et al. Genetic effects of oxidative DNA damages: comparative mutagenesis of the imidazole ring-opened formamidopyrimidines (Fapy lesions) and 8-oxo-purines in simian kidney cells. Nucleic Acids Res. 2006;34(8):2305\u201315.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"228_CR33","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.3390\/ijms14023467","volume":"14","author":"S Borrego","year":"2013","unstructured":"Borrego S, Vazquez A, Dasi F, Cerda C, Iradi A, Tormos C, et al. Oxidative stress and DNA damage in human gastric carcinoma: 8-Oxo-7\u20328-dihydro-2\u2032-deoxyguanosine (8-oxo-dG) as a possible tumor marker. Int J Mol Sci. 2013;14(2):3467\u201386.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"228_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.freeradbiomed.2011.10.439","volume":"52","author":"S Loft","year":"2012","unstructured":"Loft S, Svoboda P, Kawai K, Kasai H, Sorensen M, Tjonneland A, et al. Association between 8-oxo-7,8-dihydroguanine excretion and risk of lung cancer in a prospective study. Free Radic Biol Med. 2012;52(1):167\u201372.","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"228_CR35","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/carcin\/18.9.1763","volume":"18","author":"S Asami","year":"1997","unstructured":"Asami S, Manabe H, Miyake J, Tsurudome Y, Hirano T, Yamaguchi R, et al. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis. 1997;18(9):1763\u20136.","journal-title":"Carcinogenesis"},{"issue":"11","key":"228_CR36","first-page":"2546","volume":"56","author":"S Asami","year":"1996","unstructured":"Asami S, Hirano T, Yamaguchi R, Tomioka Y, Itoh H, Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res. 1996;56(11):2546\u20139.","journal-title":"Cancer Res"},{"issue":"3","key":"228_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/carcin\/22.3.395","volume":"22","author":"A Besaratinia","year":"2001","unstructured":"Besaratinia A, Van Schooten FJ, Schilderman PA, De Kok TM, Haenen GR, Van Herwijnen MH, et al. A multi-biomarker approach to study the effects of smoking on oxidative DNA damage and repair and antioxidative defense mechanisms. Carcinogenesis. 2001;22(3):395\u2013401.","journal-title":"Carcinogenesis"},{"issue":"2","key":"228_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.freeradbiomed.2010.11.009","volume":"50","author":"R Andreoli","year":"2011","unstructured":"Andreoli R, Mutti A, Goldoni M, Manini P, Apostoli P, De Palma G. Reference ranges of urinary biomarkers of oxidized guanine in (2\u2032-deoxy)ribonucleotides and nucleic acids. Free Radic Biol Med. 2011;50(2):254\u201361.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"228_CR39","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.freeradbiomed.2003.07.003","volume":"35","author":"SM Harman","year":"2003","unstructured":"Harman SM, Liang L, Tsitouras PD, Gucciardo F, Heward CB, Reaven PD, et al. Urinary excretion of three nucleic acid oxidation adducts and isoprostane F (2) alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med. 2003;35(10):1301\u20139.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"228_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1756-8935-6-10","volume":"6","author":"GP Pfeifer","year":"2013","unstructured":"Pfeifer GP, Kadam S, Jin SG. 5-hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin. 2013;6(1):10.","journal-title":"Epigenetics Chromatin"},{"key":"228_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13148-018-0505-0","volume":"10","author":"T Dziaman","year":"2018","unstructured":"Dziaman T, Gackowski D, Guz J, Linowiecka K, Bodnar M, Starczak M, et al. Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel disease. Clin Epigenetics. 2018;10:72.","journal-title":"Clin Epigenetics"},{"issue":"24","key":"228_CR42","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1158\/0008-5472.CAN-11-2023","volume":"71","author":"SG Jin","year":"2011","unstructured":"Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, Schackert G, et al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 2011;71(24):7360\u20135.","journal-title":"Cancer Res"},{"issue":"3","key":"228_CR43","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10120-014-0409-4","volume":"18","author":"C Du","year":"2015","unstructured":"Du C, Kurabe N, Matsushima Y, Suzuki M, Kahyo T, Ohnishi I, et al. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer. Gastric Cancer. 2015;18(3):516\u201325.","journal-title":"Gastric Cancer"},{"issue":"11","key":"228_CR44","doi-asserted-by":"publisher","first-page":"e0188856","DOI":"10.1371\/journal.pone.0188856","volume":"12","author":"M Foksinski","year":"2017","unstructured":"Foksinski M, Zarakowska E, Gackowski D, Skonieczna M, Gajda K, Hudy D, et al. Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2\u2032-deoxycytidine level in cultured cancerous cell lines. PLoS One. 2017;12(11):e0188856.","journal-title":"PLoS One"},{"key":"228_CR45","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3389\/fonc.2020.00667","volume":"10","author":"YL Yan","year":"2020","unstructured":"Yan YL, Huang ZN, Zhu Z, Cui YY, Li MQ, Huang RM, et al. Downregulation of TET1 promotes bladder Cancer cell proliferation and invasion by reducing DNA Hydroxymethylation of AJAP1. Front Oncol. 2020;10:667.","journal-title":"Front Oncol"},{"issue":"12","key":"228_CR46","doi-asserted-by":"publisher","first-page":"e0144859","DOI":"10.1371\/journal.pone.0144859","volume":"10","author":"D Gackowski","year":"2015","unstructured":"Gackowski D, Zarakowska E, Starczak M, Modrzejewska M, Olinski R. Tissue-specific differences in DNA modifications (5-Hydroxymethylcytosine, 5-Formylcytosine, 5-Carboxylcytosine and 5-Hydroxymethyluracil) and their interrelationships. PLoS One. 2015;10(12):e0144859.","journal-title":"PLoS One"},{"issue":"12","key":"228_CR47","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/nchem.2064","volume":"6","author":"M Bachman","year":"2014","unstructured":"Bachman M, Uribe-Lewis S, Yang X, Williams M, Murrell A, Balasubramanian S. 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat Chem. 2014;6(12):1049\u201355.","journal-title":"Nat Chem"},{"issue":"6512","key":"228_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1126\/science.aba7300","volume":"370","author":"R Li","year":"2020","unstructured":"Li R, Du Y, Chen Z, Xu D, Lin T, Jin S, et al. Macroscopic somatic clonal expansion in morphologically normal human urothelium. Science. 2020;370(6512):82\u20139.","journal-title":"Science"},{"issue":"5","key":"228_CR49","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","volume":"110","author":"ML Cutress","year":"2012","unstructured":"Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. 2012;110(5):614\u201328.","journal-title":"BJU Int"},{"issue":"1","key":"228_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupret","year":"2021","unstructured":"Roupret M, Babjuk M, Burger M, Capoun O, Cohen D, Comperat EM, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. 2021;79(1):62\u201379.","journal-title":"Eur Urol"},{"issue":"6","key":"228_CR51","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.euo.2018.06.007","volume":"1","author":"MC Kriegmair","year":"2018","unstructured":"Kriegmair MC, Bertolo R, Karakiewicz PI, Leibovich BC, Ljungberg B, Mir MC, et al. Systematic review of the Management of Local Kidney Cancer Relapse. Eur Urol Oncol. 2018;1(6):512\u201323.","journal-title":"Eur Urol Oncol"},{"issue":"45","key":"228_CR52","doi-asserted-by":"publisher","first-page":"e13102","DOI":"10.1097\/MD.0000000000013102","volume":"97","author":"YE Yoon","year":"2018","unstructured":"Yoon YE, Lee HH, Kim KH, Park SY, Moon HS, Lee SR, et al. Focal therapy versus robot-assisted partial nephrectomy in the management of clinical T1 renal masses: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97(45):e13102.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"228_CR53","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.urolonc.2009.06.003","volume":"29","author":"MD Azemar","year":"2011","unstructured":"Azemar MD, Comperat E, Richard F, Cussenot O, Roupret M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 2011;29(2):130\u20136.","journal-title":"Urol Oncol"},{"key":"228_CR54","volume-title":"Safety Alerts & Advisories. U.S. Food and Drug Administration","author":"Aristolochic Acid: Safety alert","year":"2015","unstructured":"Aristolochic Acid: Safety alert. In: Safety Alerts & Advisories. U.S. Food and Drug Administration. 2015. http:\/\/wayback.archive-it.org\/7993\/20171114232638\/https:\/\/www.fda.gov\/Food\/RecallsOutbreaksEmergencies\/SafetyAlertsAdvisories\/ucm095272.htm. Accessed 11 May 2021."},{"issue":"4","key":"228_CR55","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2169\/internalmedicine.40.296","volume":"40","author":"A Tanaka","year":"2001","unstructured":"Tanaka A, Nishida R, Yoshida T, Koshikawa M, Goto M, Kuwahara T. Outbreak of Chinese herb nephropathy in Japan: are there any differences from Belgium? Intern Med. 2001;40(4):296\u2013300.","journal-title":"Intern Med"},{"issue":"1","key":"228_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.55.1","volume":"55","author":"TP Truong","year":"2015","unstructured":"Truong TP, Sakata-Yanagimoto M, Yamada M, Nagae G, Enami T, Nakamoto-Matsubara R, et al. Age-dependent decrease of DNA Hydroxymethylation in human T cells. J Clin Exp Hematop. 2015;55(1):1\u20136.","journal-title":"J Clin Exp Hematop"},{"issue":"12","key":"228_CR57","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1016\/j.neurobiolaging.2012.02.006","volume":"33","author":"S Dzitoyeva","year":"2012","unstructured":"Dzitoyeva S, Chen H, Manev H. Effect of aging on 5-hydroxymethylcytosine in brain mitochondria. Neurobiol Aging. 2012;33(12):2881\u201391.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"228_CR58","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/nn.2959","volume":"14","author":"KE Szulwach","year":"2011","unstructured":"Szulwach KE, Li X, Li Y, Song CX, Wu H, Dai Q, et al. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci. 2011;14(12):1607\u201316.","journal-title":"Nat Neurosci"},{"issue":"4","key":"228_CR59","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.fertnstert.2013.05.039","volume":"100","author":"TG Jenkins","year":"2013","unstructured":"Jenkins TG, Aston KI, Cairns BR, Carrell DT. Paternal aging and associated intraindividual alterations of global sperm 5-methylcytosine and 5-hydroxymethylcytosine levels. Fertil Steril. 2013;100(4):945\u201351.","journal-title":"Fertil Steril"},{"issue":"4","key":"228_CR60","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbrc.2012.05.061","volume":"422","author":"N Huang","year":"2012","unstructured":"Huang N, Tan L, Xue Z, Cang J, Wang H. Reduction of DNA hydroxymethylation in the mouse kidney insulted by ischemia reperfusion. Biochem Biophys Res Commun. 2012;422(4):697\u2013702.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"228_CR61","doi-asserted-by":"publisher","first-page":"11474","DOI":"10.1096\/fj.201902957RR","volume":"34","author":"Y Gu","year":"2020","unstructured":"Gu Y, Chen J, Zhang H, Shen Z, Liu H, Lv S, et al. Hydrogen sulfide attenuates renal fibrosis by inducing TET-dependent DNA demethylation on klotho promoter. FASEB J. 2020;34(9):11474\u201387.","journal-title":"FASEB J"}],"container-title":["Genes and Environment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41021-021-00228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41021-021-00228-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41021-021-00228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T04:54:21Z","timestamp":1676004861000},"score":1,"resource":{"primary":{"URL":"https:\/\/genesenvironment.biomedcentral.com\/articles\/10.1186\/s41021-021-00228-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["228"],"URL":"https:\/\/doi.org\/10.1186\/s41021-021-00228-9","relation":{},"ISSN":["1880-7062"],"issn-type":[{"type":"electronic","value":"1880-7062"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"15 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed in accordance with the Declaration of Helsinki and the use of residual pathological tissue in this research was approved by the Institutional Review Board of Hamamatsu University School of Medicine (No. 20\u2013011).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}